麻豆传媒

Trusted by:

clients clients clients clients clients clients clients clients clients clients
麻豆传媒: Changing Guidelines for Treating Mild Chronic Hypertension in Pregnancy
Released: 28-Apr-2022 10:05 AM EDT
Changing Guidelines for Treating Mild Chronic Hypertension in Pregnancy
Ochsner Health

Based upon a clinical trial of pregnant women at more than 70 sites, including Ochsner Health, doctors are recommending that even mild forms of high blood pressure be treated with medication.

18-Jul-2022 4:20 PM EDT
Ochsner Study Shows that Social Circumstances Have Outsized Impact on Hypertension Control
Ochsner Health

A research article published in the Mayo Clinic Proceedings highlights the significant impact of social determinants of health on patients鈥 ability to sustain control of hypertension.

麻豆传媒: JACC study makes case for expanding coverage for carotid artery stenting
Released: 3-Aug-2022 11:05 AM EDT
JACC study makes case for expanding coverage for carotid artery stenting
Ochsner Health

Research from Ochsner Health published in the Journal of the American College of Cardiology advises expanding insurance coverage for carotid artery stenting.

麻豆传媒: Ochsner and Tulane collaboration uncovers what happens to genes inside artery plaques to trigger strokes
Released: 11-Aug-2022 4:40 PM EDT
Ochsner and Tulane collaboration uncovers what happens to genes inside artery plaques to trigger strokes
Ochsner Health

Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that become active in carotid arteries when plaque rupture causes a stroke. The work, published in Scientific Reports, was made possible by acquiring samples closer to the time of the stroke than previously possible. The results provide a picture of what the cells in the plaque are doing near the moment they induce a stroke.

Released: 21-Sep-2022 12:55 PM EDT
Study Finds Reasons for Differences in Cost and Savings in Medicare Programs Not Yet Defined
Ochsner Health

A retrospective study of data from Ochsner Health explores cost and savings differences between Medicare Advantage and Medicare Shared Savings Program beneficiaries.

麻豆传媒: Ochsner Pharmacist Makes Case for Reducing Use of Broad-Spectrum Antibiotics for Acute Kidney Infections
Released: 2-Nov-2022 5:40 PM EDT
Ochsner Pharmacist Makes Case for Reducing Use of Broad-Spectrum Antibiotics for Acute Kidney Infections
Ochsner Health

A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.

麻豆传媒: Ochsner Health neuropsychologist publishes playbook on implementing value-based dementia care
Released: 22-Feb-2023 1:45 PM EST
Ochsner Health neuropsychologist publishes playbook on implementing value-based dementia care
Ochsner Health

The New England Journal of Medicine (NEJM) Catalyst recently published an article by Ochsner Health neuropsychologist and a team of researchers discussing the critical need for value-based care models for patients with dementia.

Released: 16-Mar-2023 2:30 PM EDT
New Trials Show Promising, Minimally Invasive Procedure to Treat Resistant Hypertension
Ochsner Health

A recent study published in JAMA demonstrates the effectiveness of a procedure done under the skin, similar to placing a stent, to treat uncontrolled hypertension, or blood pressure that cannot be controlled despite the use of blood pressure control drugs and agents.

Released: 13-Apr-2023 5:25 PM EDT
Prestigious New England Journal of Medicine Publishes Ochsner Health鈥檚 Research into Alternative to Amputation
Ochsner Health

Ochsner Health is one of 20 sites in the U.S. participating in the PROMISE II clinical trial, which was recently published in the New England Journal of Medicine.

麻豆传媒: Ochsner Participates in New Study Showing Potential Benefits of Normothermic Machine Perfusion in Liver Transplantation
Released: 17-Jul-2023 2:10 PM EDT
Ochsner Participates in New Study Showing Potential Benefits of Normothermic Machine Perfusion in Liver Transplantation
Ochsner Health

The randomized controlled study was conducted by 15 liver transplant centers in the United States, including Ochsner Health Liver Transplant Institute, and compared the use of normothermic machine preservation (NMP)鈥攚hich maintains the organ at normal body temperature-- with static cold storage (SCS) in 383 donor organs.


close
1.61716